Skip to main content
Erschienen in: BMC Women's Health 1/2021

Open Access 01.12.2021 | Research article

Barriers and facilitators for cervical cancer screening among adolescents and young people: a systematic review

verfasst von: Abirami Kirubarajan, Shannon Leung, Xinglin Li, Matthew Yau, Mara Sobel

Erschienen in: BMC Women's Health | Ausgabe 1/2021

Abstract

Background

Though cervical cancer is one of the leading causes of cancer-related death globally, its incidence is nearly entirely preventable. Young people have been an international priority for screening as this population has historically been under-screened. However, in both high-income and low-income countries, young people have not been screened appropriately according to country-specific guidelines. The aim of this systematic review was to systematically characterize the existing literature on barriers and facilitators for cervical cancer screening (CCS) among adolescents and young people globally.

Methods

We conducted a systematic review following PRISMA guidelines of three key databases: Medline-OVID, EMBASE, and CINAHL. Supplementary searches were done through ClinicialTrials.Gov and Scopus. Databases were examined from 1946 until the date of our literature searches on March 12th 2020. We only examined original, peer-reviewed literature. Articles were excluded if they did not specifically discuss CCS, were not specific to individuals under the age of 35, or did not report outcomes or evaluation. All screening, extraction, and synthesis was completed in duplicate with two independent reviewers. Outcomes were summarized descriptively. Risk of bias for individual studies was graded using an adapted rating scale based on the Risk of Bias Instrument for Cross-Sectional Surveys of Attitudes and Practices.

Results

Of the 2177 original database citations, we included 36 studies that met inclusion criteria. The 36 studies included a total of 14,362 participants, and around half (17/36, 47.2%) of studies specifically targeted students. The majority of studies (31/36, 86.1%) discussed barriers and facilitators to Pap testing specifically, while one study analyzed self-sampling (1/36, 2.8%), one study targeted HPV DNA testing (1/36, 2.8%), and the remainder (4/36, 11.1%) were not specified. Our systematic review found that there are three large categories of barriers for young people: lack of knowledge/awareness, negative perceptions of the test, and systemic barriers to testing. Facilitators included stronger relationships with healthcare providers, social norms, support from family, and self-efficacy.

Conclusion

There are unique barriers and facilitators that affect CCS rates in adolescents and young people. Health systems and healthcare providers worldwide should address the challenges for this unique population.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CCS
Cervical cancer screening
HPV
Human papillomavirus
PRISMA
Preferred Reporting Items for Systematic Reviews and Meta-Analysis

Background

Cervical cancer is the second most common malignancy among women worldwide, with over 600,000 new cases and 300,000 deaths annually [13]. The disease is frequently caused by the human papillomavirus (HPV), which is sexually transmitted [1]. Though cervical cancer is one of the leading causes of death globally, its incidence is nearly entirely preventable [4]. Cervical cancer screening (CCS) and HPV vaccination programs have significantly reduced the mortality of cervical cancer in North America and Europe through secondary prevention. Screening techniques include Papanicolau tests (also known as Pap smears), liquid-based cytology, HPV DNA testing, and visual inspection with acetic acid [5, 6]. Through timely CCS, patients can obtain referrals to colopscopy and receive definitive treatment for abnormal cervical cells or malignancy. Despite the proven effectiveness of CCS, there are numerous barriers to uptake, particularly in low-income countries [7].
Young people have been a particular area of research focus, due to the preventive benefits of screening from a younger age, increased likelihood of lifelong testing, and setting of new cultural norms [811]. In both high-income and low-income countries, young people have not been screened appropriately according to country-specific guidelines and in many countries, screening rates for this age-group have even dropped [1216].
As a result, numerous interventions have been posited to increase CCS among young people [8]. However, there has not yet been a systematic assessment of the barriers and facilitators that determine uptake among this age-group. This information would be useful in designing targeted and efficacious interventions. The aim of this systematic review was to systematically characterize the global literature on barriers and facilitators for CCS among young people.

Methods

This systematic review was conducted and reported according to the standards and guidelines established in the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), in addition to the fourth edition of the Joanna Briggs Institute Reviewer’s Manual [17, 18].

Search strategy

We conducted a systematic literature search of three key databases: Medline-OVID, EMBASE, and CINAHL. Supplementary searches were done through ClinialTrials.gov and Scopus.
Our search criteria included broad keywords and subject headings in order to maximize sensitivity. We did not apply any filters on the basis of language or country of origin. Our search strategy is included in Table 1.
Table 1
Search strategy
#
Searches
1
VAGINAL SMEARS/
2
(vagina* AND smear*).ti,ab
3
(pap AND test). ti,ab
4
cytology.ti,ab
5
(pap AND smear). ti,ab
6
(cervical adj2 (smear OR screen*)).ti,ab
7
(papanicolaou adj2 (smear OR test*)).ti,ab
8
1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7
9
(youth* or adolescen* or (young adj2 (adult* or person* or individual* or people* or population* or wom#n)) or youngster* or college* or university*).ti,ab. or adolescent/ or young adult/
10
(barrier* OR facilitator* OR perception* OR perspective* OR utilization* OR view*).ti,ab
11
8 AND 9 AND 10
Database: Ovid MEDLINE: Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE® Daily and Ovid MEDLINE®
1946—March 12 2020
Adapted for EMBASE and CINAHL

Selection criteria

We defined the study population as individuals under the age of 35. The maximum age was determined based on previous literature regarding young people and CCS [8, 12]. There was no cut-off for a minimum age, as we were interested to examine the earliest age at which adolescents or young adults were screened.We only examined original, peer-reviewed literature. Databases were examined from inception until the date of our literature searches on March 12th 2020. Published conference posters, papers, and abstracts were eligible for inclusion. Articles were excluded if they did not specifically discuss CCS, were not specific to young people under the age of 35 (as reported in the title or abstract), or did not report outcomes or evaluation. Studies with transgender men, cisgender women, and intersex people with cervixes were eligible for inclusion. Eligibility criteria are outlined in Table 2.
Table 2
Eligibility criteria
Population: Young people (defined as 35 years of age or under) with cervixes of any country worldwide
 
Intervention: Any assessment of patient-reported barriers and facilitators related to cervical cancer screening
 
Comparator: N/A
 
Outcomes: Any outcome reported in the literature (qualitative or quantitative)
 

Data extraction and quality assessment

All steps of the systematic review were performed in duplicate. Study selection was completed by two independent, parallel reviewers (AK, SL) for both title and abstract screening as well as full-text screening. Data extraction was performed by two investigators (AK, SL), with a third (XL) resolving discrepancies. Risk of bias for individual studies was graded using an adapted rating scale based on the Risk of Bias Instrument for Cross-Sectional Surveys of Attitudes and Practices [19].

Analysis

Outcomes were summarized descriptively via thematic analysis. Thematic analysis was decided via consensus approach by the two reviewers (AK, SL). We did not register our systematic review to allow for iterative categorization. In addition, it was decided a priori that a meta-analysis would not be suitable for this review, due to the heterogeneity of the included articles.

Results

Results of the study screening process are available in the PRISMA diagram in Fig. 1. Of the 2177 original database citations, 1563 records remained after duplicates were removed. After title and abstract screening, 226 were eligible for full-text evaluation. After a hand-search of relevant journals and citations, no additional studies were added. Of the 226 full-text articles, a total of 36 were included in the systematic review.
Inter-rater agreement for study screening for titles and abstracts was 94.54% with a kappa of 0.79. Inter-rater agreement for full-text screening was 96.2% with a kappa of 0.84, indicating substantial agreement.

Article characteristics

The study locations were highly diverse and featured a wide spread across Africa (8/36, 22.2%), Asia (8/36, 22.2%), North America (11/36, 30.6%), South America (2/36, 5.6%), Australia (1/36, 2.8%), Europe (6/36, 16.7%). High-income countries included the United States, Canada, Denmark, Sweden, Japan, Korea, Australia, and the United Kingdom. Low- and middle-income countries included Brazil, China, Ghana, Malaysia, Nigeria, Oman, and Saudi Arabia.
The included study designs were largely qualitative and observational. The majority (25/36, 69.4%) included either surveys or questionnaires, with the remainder including either focus groups (7/36, 19.4%) or interviews (2/36, 5.6%). All studies were graded as medium risk for bias using the Risk of Bias Instrument for Cross-Sectional Surveys of Attitudes and Practices.
The 36 studies included a total of 14,362 participants, and around half (17/36, 47.2%) of studies specifically targeted students.
The majority of studies (31/36, 86.1%) discussed barriers and facilitators to Pap testing specifically, while one study analyzed self-sampling (1/36, 2.8%), one study targeted HPV DNA testing (1/36, 2.8%), and the remainder (4/36, 11.1%) were not specified.
Details of the included studies are provided in Table 3.
Table 3
Details of included studies
References; Country
Study design; graded Risk of Bias
Sample size; population details
Average age (SD)
Type of screening
Barriers
Facilitators
Abotchie and Shokar [20]; Ghana
Cross-sectional survey; medium risk
157 university students
NR (age range 20–35, most between 21 and 25)
Pap smear
Low knowledge, low awareness, concern regarding partner disapproval, cost, time constraints, embarrassment, perceived not susceptible, fear of virginity loss
Knowledge of benefits of screening, perception of severity of disease
Agboeze et al. [21]; Nigeria (Abstract only)
Cross-sectional survey; medium risk
234 female students
22 (SD 3)
Pap smear
Low awareness, low accessibility, fear of cancer diagnosis
NR
Akujobi et al. [22]; Nigeria (Abstract only)
Cross-sectional survey; medium risk
220 third and fourth year female science students
23.8 (SD NR)
Pap smear
Lack of knowledge, lack of awareness about importance of screening, lack of awareness about where services are attainable
NR
Al-Naggar et al. [23]; Malaysia
Cross-sectional survey; medium risk
287 female university students
20.9 (SD 1.89)
Pap smear
Fear of intimate nature of examination, HCP did not recommend/educate, lack of awareness of screening sites, cost, fear of virginity loss, embarrassment, fear of pain and discomfort
NR
Al-Shaikh et al. [24]; Saudi Arabia
Cross-sectional survey; medium risk
1400 students studying health fields
20.4 (SD 1.3)
Pap smear
Lack of awareness, perception of low sensitivity of test, misconception of serious complications of test
NR
Albuquerque et al. [25]; Brazil
Cross-sectional survey; medium risk
493 women,, young women (< 20) n = 64
35.4 (SD NR)
Pap smear
Low knowledge and awareness
NR
Alwahaibi et al. [26]; Oman
Cross-sectional survey; medium risk
494: 204 patients, 133 staff, 157 students
NR (students all age 20–30)
Pap smear
Low knowledge, lack of awareness, physician gender, uncertainty of reliability of Pap smears
Belief of test allowing successful prevention and treatment for cancer
Annan et al. [27]; Ghana
Cross-sectional survey; medium risk
200 female university students
20.4 (SD 1.96)
Unspecified
NR
Cervical cancer knowledge, perceived susceptibility, perceived deadliness, perceived benefits of screening
Ayinde et al. [28]; Nigeria
Cross-sectional survey; medium risk
421 undergraduate students
23.6 (SD 3.6)
Pap smear
Lack of awareness
Increased knowledge and awareness
Bigaard et al. [29]; Denmark (Abstract only)
Qualitative focus groups (cross-sectional); medium risk
Sample size not reported in abstract; HPV vaccinated women
NR (age range 23–29)
Pap smear
Lack of knowledge, perceived not susceptible (test not relevant to them)
NR
Binka et al. [30]; Ghana
Cross-sectional survey; medium risk
410 female students
NR (83% < 29 years; 17% > 30)
Unspecified
Lack of awareness
NR
Black et al. [31]; Canada
Cross-sectional focus groups; medium risk
80 women
NR (98% between age 20 and 29)
Pap smear
Discontinuity of care from HCP after moving away for work/school, difficulty finding female HCP, fear of discomfort and invasiveness of test, lack of awareness, lack of time
Reminders, email from HCP, linking testing to renewal appointment for oral contraceptives, assistance with finding HCP, longitudinal relationship with HCP or clinic, education, testing by female HCP, increased convenience (e.g. clinic on campus)
Blomberg et al. [32]; Sweden
Cross-sectional focus groups; medium risk
138 women from Stockholm cervical cancer screening registry
30 (SD 0)
Pap smear
Fear of pain and discomfort
Letter of invitation, flexibility in timing and location, choice of HCP, having test done with other exams, social marketing on importance of screening, cost-free testing
Blomberg et al. [33]; Sweden
Cross-sectional focus groups; medium risk
38 women from Cervical Cancer Screening administrative registry
30 (SD 0)
Pap smear
Lack of knowledge, lack of awareness, perceived not susceptible
Existing relationship with clinic
Byrd et al. [34]; United States
Cross-sectional survey; medium risk
200 women
21 (SD NR)
Pap smear
Embarrassment, pain, embarrassment, fear of virginity loss, lack of awareness of where to be tested, fear of partner disapproval, misconception (only women who have had babies) need to be tested, fear of testing perceived as sexual activity
NR
Duffet-Leger et al. [35]; Canada
Cross-sectional survey; medium risk
1041 university students
20.7 (SD 1.77)
Pap smear
NR
Beliefs/behaviours of friends and family, sense of empowerment about getting Pap test
Head and Cohen [36]; United States
Cross-sectional individual and group interviews; medium risk
19 women
NR (median age of 20)
Pap smear
Negative past experiences, limited choice in HCP, fear of parental disapproval, cost, low accessibility, lack of privacy in small community (e.g. running into someone they know at the clinic)
Encouragement/support from mother
Hobbs [37]; United States (Abstract only)
Qualitative focus groups; medium risk
15 sexually active adolescents
18.7 (SD NR)
Pap smear
Lack of knowledge, fear of pain, embarrassment, fear of result, fear of unknown, perceived invincibility, HCP characteristics, fear of parents finding out, cost, lack of time, transportation
Education, trusting relationship with HCP, HCPs able to communicate well and put patients at ease, assured confidentiality, school programs, shorter wait times, telephone/email reminders, provision of babysitting or transportation, expanded clinic hours, having someone answer the phone when patients book appointments
Hoque [38], South Africa
Questionnaire; medium risk
169 full-time undergraduate students
20.81 (SD 1.7)
Pap smear
Low knowledge, fear of procedure, not currently experiencing symptoms
NR
Hoque [39], South Africa (Abstract only)
Questionnaire; medium risk
440 university students
20.39 (SD 1.71)
Pap smear
Low knowledge
High self-efficacy
Jayasinghe [40], Australia
Online survey; medium risk
149 women
23.2 (SD 2.1)
HPV DNA testing
Repetitive screening frequency
Public perceptions, national guidelines, gynecologist beliefs
Jubelirer [41]; United States
Questionnaire; medium risk
279 tenth-grade girls
15.3 (SD NR)
Pap smear
Embarrassment, pain, fear of cancer, confidentiality, cost
NR
Kahn [42], United States
Semi-structured interview; medium risk
15 adolescents
18.7 (SD 1.9)
Pap smear
Pain, embarrassment, fear of cancer, denial, poor HCP relationship, low knowledge, misinformation
Education, better HCP relationships, telephone and written reminders
Kahn [28], United States
Questionnaire; medium risk
490 adolescents and young girls at pap smear follow-up clinics
18.2 (SD NR)
Pap smear
Pain, inconsistent HCP, embarrassment, lack of HFP communication, lack of time, lack of transportation
Reminders, perceived control, perceived susceptibility
Kaneko [43], Japan
Online survey; medium risk
700 unmarried women
26.0 (SD NR)
Pap smear
Male physician
Free coupon for screening, perceived susceptibility
Kim [44], Korea (Abstract only)
Questionnaire; medium risk
303 unmarried female university students
22.4 (SD 2.0)
Pap smear
Low knowledge/awareness
NR
Kim [45], Korea (Abstract only)
Online questionnaire; medium risk
124 unmarried university students
NR
Pap smear
Unsure of effectiveness, low awareness
Subjective norm
Langille [46], Canada
Questionnaire; medium risk
1090 high school adolescents
16.6 (SD 0.1)
Pap smear
Lack of discussion with HCP, no physician, rural area
Education from HCP
Lee [47], United States
Focus group; medium risk
16 young Korean immigrant women
26 (SD NR)
Pap smear
Low knowledge, culture-specific barriers, low accessibility to healthcare, embarrassment, fear of virginity loss, stigma around visiting gynecologist clinic, language barriers, low health literacy
NR
Lorenzi [39],Brazil
Survey; medium risk
33 women with abnormal pap smears
NR (aged < 29)
Self-sampling
Embarrassment, pain
Easy to use, easy to understand, practicality
Najem [48], United States
Survey; medium risk
3343 inner city high school girls
NR (aged 13 and up)
Pap smear
HCP did not recommend, lack of awareness, cost, unaware of location, perceived not susceptible, time constraints, believed test was not accurate, embarrassment, time constraint
Family role models
Ogbonna [49], United Kingdom
Survey; medium risk
186 UK university students from Sub-Saharan Africa
NR (majority between age 18 and 24)
Pap smear
Low knowledge, misconceptions (such as around circumcision), cultural barriers, stigma
Perception of deadliness
Okoeki [50], United Kingdom
Semi-structured interviews, focus group; medium risk
24 young women
NR (age range 25–34)
Pap smear
Low awareness, embarassment, anxiety, association with sex, intimate, cultural barriers, fear of cancer, invasiveness
Education on sensitivity, education, alternative screening methods (self-sampling)
Oshima [51], Japan
Focus group; medium risk
15 university students
NR (age 20–22)
Pap smear
Lack of knowledge,misconceptions, lack of motivation, reluctance to visit gynecologist (embarrassment, stigma, invasiveness)
Media information, norms of family and friends, diagnosis within their family, education
Pan [52], China
Survey; medium risk
1878 medical students
20.8 (SD 1.3)
Unspecified
Side effects, inadequate information, low knowledge, stigma around premarital sex
High knowledge
Waller [53], United Kingdom
Interview, focus group; medium risk
27 young women
NR (age range between 25 and 34 for young women)
Unspecified
Lack of access to HCP (mobility, lack of consistency), fewer reminders, time constraints, lack of peer pressure, low perceived low perceptibility, menstrual cycle timing, low knowledge, pain, uncomfortable comments, apathy
Awareness, media coverage

Analysis of notable barriers

There were numerous barriers cited by the young people and adolescents regarding CCS. The barriers can be grouped into three large groups: lack of knowledge/awareness, negative perceptions of testing, and practical barriers.
(i)
Lack of Knowledge/Awareness
 
Most notably, 26/36 (72.2%) of studies reported lack of knowledge or awareness in young people regarding cervical cancer prevention. Three studies [23, 46, 48] noted lack of physician recommendation, while one noted gaps in health literacy of the participants [47].
Misinformation included beliefs that young people were not susceptible in 4/36 studies [20, 32, 48, 53], that screening was not necessary if not currently experiencing symptoms [38], and that the Pap test was not effective/reliable for screening cervical cancer [26, 45]. Other misconceptions included that a cisgender male partner’s circumcision prevented their need for CCS [49]. In four studies, there was a fear that pelvic exams could “take one’s virginity,” reported in Ghana, Malaysia, and the United States [20, 23, 34, 47].
(ii)
Negative Perceptions of Testing
 
A large number of young people had fears and anxieties regarding the screening experience. Ten studies cited a fear of pain/discomfort during Pap smears, with 13/36 studies noting embarrassment of the intimate examination. Three studies noted the invasiveness of the procedure being of particular concern [31, 50, 51]. Male physicians were also noted to impede motivation for screening in two studies [31, 43].
Stigma around cervical cancer was noted in 4 studies [47, 49, 51, 52], with two of the studies reporting stigma around the general act of visiting a gynecologist’s office [47, 51]. Confidentiality was a concern noted in three studies [36, 37, 41], with two specifically noting privacy from parents [36, 37].
Two studies discussed fear of side effects or complications from screening [24, 52]. Five studies discussed fear regarding potential diagnosis of cancer as a barrier to screening [21, 37, 41, 42, 50].
(iii)
Systemic Barriers on Organizational Level
 
There were a number of systemic barriers noted to accessing CCS.
Six studies discussed low accessibility to services [21, 31, 36, 46, 47, 53]. Participants reported difficulties in finding a consistent healthcare provider, especially after moving away for work or school [31, 53]. Difficulties were also noted in rural areas with only a single provider [20] or locations with reduced access to female physicians [31].
Transportation was noted as a barrier in two studies [37, 54]. Cost of screening services and financial constraints were noted as a barrier in six studies [20, 23, 36, 37, 41, 48], with two studies located in lower income countries (Ghana, Malaysia) and the remainder in the United States.
Time constraints were cited in three studies [20, 48, 53]. One study noted that participants preferred to schedule their appointments according to their menstrual cycle, which posed further limitations [53].

Analysis of notable facilitators

Many studies discussed facilitators and interventions that encouraged young people to undergo CCS. Increased knowledge and awareness were noted in twelve studies [20, 2628, 37, 40, 42, 4953]. Specific points of knowledge included severity of disease [20, 49], as well as the understanding that the test could allow successful prevention and treatment of cancer [26]. High self-efficacy and perceived control/empowerment about health was a facilitator in three studies [54, 55, 35].
Trusting and longitudinal relationships with their healthcare providers were noted as facilitators in four studies [31, 32, 37, 42], as was choice of healthcare provider specifically [32] or testing by a female physician [31]. Hobbs et al. [37] specifically noted that physicians who were able to communicate well and put patients at ease acted as a facilitator. Alternative methods of screening such as self-sampling were noted as a facilitator of CCS to avoid perceived invasiveness [50, 39].
Social norms and public perceptions, including if friends and family members received testing, was noted as a facilitator [35, 36, 40, 45, 48, 51]. A diagnosis of cervical cancer in the family was noted as a motivation for undergoing screening [51], as well as support or encouragement from one’s mother specifically [36]. Media coverage was noted to encourage participation in CCS, particularly if involving celebrities or public figures [50, 53].
Facilitators to improve the logistical barriers of cervical cancer were analyzed. Five studies noted either telephone or written reminders would be helpful for patients [31, 32, 37, 42, 54]. To address the time constraints of patients, Black et al. [31] and Blomberg et al. [32] noted that cervical screening could be linked with appointments for prescription renewals or other examinations. In addition, Blomberg et al. [32] suggested flexibility in time and location of screening, including options such as screening available on college campuses. Shorter wait-times, expanded clinic hours, and having someone pick up the phone when patients book appointments were noted as practical options by Hobbs et al. [37]. Cost-free services, provision of babysitting services, and arranged transportation were also suggested [32, 37, 43].

Discussion

Main findings

Our study is the first systematic review of barriers and facilitators to CCS specifically for young people and adolescents under the age of 35. While there have been calls to action regarding this topic, it has been difficult to characterize the breadth of young people’s perspectives regarding screening. Our 36 included studies had a diverse spread of country locations across low-, middle- and high-income countries in addition to a range of study populations. Barriers encompassed three groups: lack of knowledge/awareness, negative perceptions of the test, and systemic barriers to testing on an organizational level. Facilitators included stronger relationships with healthcare providers, social norms, support from family, and self-efficacy.
Our results support the current literature base regarding the uptake of CCS in young people. Young people face unique barriers and facilitators in comparison to older groups, necessitating age-specific interventions. Our studies highlighted age-specific barriers such as concern about privacy from parents, transportation difficulties, and continuity of care after moving away for school. In addition, as this is typically the first invasive procedure that young people undergo, there were concerns about pain, discomfort, and the intimacy of the pelvic exam. The young people who participated in these studies had helpful suggestions regarding age-specific interventions, such as emailed reminders in comparison to written reminders, or screening provided on college campuses. Our literature also aligns with the greater research base regarding young people and low preventative service use in general, as many young people do not have a consistent family physician [56, 57]. As such, other studies have also noted that age is a consideration for cancer screening beliefs or adherence to cancer screening programs [58, 59].
When comparing results internationally, we noticed that many themes were universally represented across income levels. There were accessibility concerns, cost concerns, and knowledge gaps in both lower and higher income countries. However, it is important to note that screening rates differ across the globe, and even within the same country for lower income and minority populations. As financial constraints were cited as a frequent barrier in our included studies, it is not surprising that people from lower socioeconomic backgrounds have lower screening rates [60, 61]. In addition, people from minority populations may have more strained relationships with the health system due to discrimination, lack of cultural competence, and the historic failure of medical systems to be equitable towards minority groups [62, 63]. This is particularly relevant to cervical screening, as the patient’s individual relationship with the health system was noted as an important barrier or facilitator towards screening. To increase cervical screening rates, it is important that we improve health system interactions overall to be more equitable.
Additionally, we noted that cultural barriers were discussed in several studies, including sex-negative beliefs [47, 49, 50, 52]. Several studies highlighted a fear of hymen breakage with the pelvic exam, which has the societal stigma against virginity loss [20, 23, 34, 47]. This concept was not only studied in Asia and Africa, but also included two studies from the United States [34, 47]. It is important to educate about the concept of virginity as a social construct and improve sexual education. In higher-income countries, language barriers, health literacy, and cultural beliefs were also noted as barriers among recent immigrants. Recent literature has shown that the “healthy immigrant effect” tends to taper off after several decades in a new country, with immigrants at higher risk of poor health outcomes and underuse of health services [64, 65]. Specific to cervical cancer, immigrant and minority populations in developed countries are at higher risk, often due to low screening rates [66, 67]. Thus, interventions that target cervical screening uptake should have an intersectional approach in addressing these issues, rather than a “one size fits all” approach. Finally, as many participants expressed a fear of the speculum examination, it is important that both medical trainees and physicians are adequately trained regarding patient comfort during speculum exams, potentially through interventions such as gynecological teaching associates or standardized patients.

Strengths and limitations

Strengths of our review include our systematic search of multiple databases using broad search criteria to maximize findings. Studies were not excluded by basis of date of publication, country of origin, or language of origin. To capture the full breadth of explored research, conference abstracts were included. Our two parallel reviewers had high inter-rater agreement. We also included age ranges up to 35 years, based on previous literature. Limitations include that this review included qualitative studies that may have been limited by selection and publication bias, particularly for lower-income countries that may not be well-represented in academic research. Studies were also only included if the title and/or abstract explicitly discussed the age cut-off of young people, which may have inadvertently excluded relevant studies. As with any systematic review, there is a risk that relevant studies may have been excluded, despite our efforts to maximize our search's sensitivity. In addition, CCS guidelines (e.g. age to start screening) may differ depending on country, which may limit generalizability of results. Survey and interview results may also be compromised by reporting bias, if study participants are potentially embarrassed to discuss barriers or facilitators. More rigorous and systematic research with an equity-focused lens is recommended to generalize results to different populations and obtain higher quality information.

Next steps and implications for care

Further research is required to characterize which interventions are the most effective for different age groups, including a diverse range of ethnicities, sexual orientations, educational backgrounds, and income levels. Future studies may also wish to consider other factors in awareness, such as the date of implementation of the CCS program or the presence of an HPV vaccination program. Moreover, we were surprised that none of the studies specifically targetted the beliefs of non-heterosexual or non-cisnormative participants, as this has been documented as a growing public health concern and source of misinformation [6871]. Studies regarding transgender men were eligible for study inclusion, but yielded no search results based on our protocol as the identified studies were not specific to youth or young people. Further specific investigation is required to understand this topic, from both the perspective of the patient and the physician.
Our results were encouraging regarding potential solutions for improving CCS uptake. While some barriers such as fear of cancer diagnosis or longstanding cultural beliefs are difficult to address, other barriers offer feasible solutions. Younger people may have less control in their lives regarding transportation and scheduling, particularly when coordinating with parents, babysitting siblings, or school schedules. It was remarkable how many small changes, such as written reminders, pamphlets, or linking screening with other appointments, were noted to act as facilitators. In addition, multiple misconceptions about CCS still persist, such as the belief that screening is only required if a patient is experiencing symptoms. Our studies suggested the effectiveness of awareness campaigns that are specifically aimed at younger people. Campaigns targeting parents may also be important as studies noted that parental support was a facilitator for screening. We recommend further research on interventions, particularly educational resources such as information leaflets.
Through addressing the above barriers and facilitators, health systems worldwide can hopefully address the much-touted goal of zero preventable deaths from cervical cancer. Young people who undergo screening are more likely to continue the practice as a lifelong habit as well as later recommend the practice to their children and peers [811]. They are also more likely to espouse positive beliefs about the health system, sex-positive beliefs, and regain empowerment regarding their health [72, 73]. As such, every young person who is screened offers a chance of strengthening a community around reproductive health.

Conclusion

Our comprehensive systematic review found that there are three large categories of barriers for young people: lack of knowledge/awareness, negative perceptions of the test, and systemic barriers to testing. Facilitators included stronger relationships with healthcare providers, social norms, support from family, and self-efficacy. Health systems worldwide should address the above barriers and facilitators to increase CCS rates in young people.

Acknowledgments

None.

Declarations

Not applicable.
Not applicable.

Competing interests

None.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Behtash N, Mehrdad N. Cervical cancer: screening and prevention. Asian Pac J Cancer Prev. 2006;7(4):683.PubMed Behtash N, Mehrdad N. Cervical cancer: screening and prevention. Asian Pac J Cancer Prev. 2006;7(4):683.PubMed
4.
Zurück zum Zitat Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8(2):e191-203.PubMedCrossRef Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8(2):e191-203.PubMedCrossRef
5.
Zurück zum Zitat Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynecol Obstetr. 2005;89:S4-12.CrossRef Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynecol Obstetr. 2005;89:S4-12.CrossRef
6.
Zurück zum Zitat Nuovo J, Melnikow J, Howell L. New tests for cervical cancer screening. Am Fam Physician. 2001;64(5):780.PubMed Nuovo J, Melnikow J, Howell L. New tests for cervical cancer screening. Am Fam Physician. 2001;64(5):780.PubMed
7.
Zurück zum Zitat Islam RM, Billah B, Hossain MN, Oldroyd J. Barriers to cervical cancer and breast cancer screening uptake in low-income and middle-income countries: a systematic review. Asian Pacific J Cancer Prev APJCP. 2017;18(7):1751. Islam RM, Billah B, Hossain MN, Oldroyd J. Barriers to cervical cancer and breast cancer screening uptake in low-income and middle-income countries: a systematic review. Asian Pacific J Cancer Prev APJCP. 2017;18(7):1751.
8.
Zurück zum Zitat Albrow R, Blomberg K, Kitchener H, Brabin L, Patnick J, Tishelman C, Törnberg S, Sparén P, Widmark C. Interventions to improve cervical cancer screening uptake amongst young women: a systematic review. Acta Oncol. 2014;53(4):445–51.PubMedCrossRef Albrow R, Blomberg K, Kitchener H, Brabin L, Patnick J, Tishelman C, Törnberg S, Sparén P, Widmark C. Interventions to improve cervical cancer screening uptake amongst young women: a systematic review. Acta Oncol. 2014;53(4):445–51.PubMedCrossRef
9.
Zurück zum Zitat Peto J, Gilham C, Fletcher O, Matthews F. The cervical cancer screening epidemic that screening has prevented in the UK. Lancet. 2004;364:8. Peto J, Gilham C, Fletcher O, Matthews F. The cervical cancer screening epidemic that screening has prevented in the UK. Lancet. 2004;364:8.
10.
Zurück zum Zitat Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: A systematic review. Health Technol Assess 2000;4:i–vii, 1–133. Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: A systematic review. Health Technol Assess 2000;4:i–vii, 1–133.
11.
Zurück zum Zitat Ferrer HB, Trotter C, Hickman M, Audrey S. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health. 2014;14(1):700.PubMedPubMedCentralCrossRef Ferrer HB, Trotter C, Hickman M, Audrey S. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health. 2014;14(1):700.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Bradley J, Risi L, Denny L. Widening the cervical cancer screening net in a South African township: who are the underserved? Health Care Women Int. 2004;25(3):227–41.PubMedCrossRef Bradley J, Risi L, Denny L. Widening the cervical cancer screening net in a South African township: who are the underserved? Health Care Women Int. 2004;25(3):227–41.PubMedCrossRef
13.
Zurück zum Zitat Lancucki L, Fender M, Koukari A, Lynge E, Mai V, Mancini E, et al. A fall-off in cervical screening coverage of younger women in developed countries. J Med Screen. 2010;17:91–6.PubMedCrossRef Lancucki L, Fender M, Koukari A, Lynge E, Mai V, Mancini E, et al. A fall-off in cervical screening coverage of younger women in developed countries. J Med Screen. 2010;17:91–6.PubMedCrossRef
14.
Zurück zum Zitat Llorca J, Rodriguez-Cundin P, Dierssen-Sotos T, Prieto-Salceda D. Cervical cancer mortality is increasing in Spanish women younger than 50. Cancer Lett. 2006;240(1):36–40.PubMedCrossRef Llorca J, Rodriguez-Cundin P, Dierssen-Sotos T, Prieto-Salceda D. Cervical cancer mortality is increasing in Spanish women younger than 50. Cancer Lett. 2006;240(1):36–40.PubMedCrossRef
15.
Zurück zum Zitat Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008;16(32):41–9.PubMedCrossRef Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008;16(32):41–9.PubMedCrossRef
16.
Zurück zum Zitat Garland S, Park SN, Ngan HY, Frazer I, Tay EH, Chen CJ, Bhatla N, Pitts M, Shin HR, Konno R, Smith J. The need for public education on HPV and cervical cancer prevention in Asia: opinions of experts at the AOGIN conference. Vaccine. 2008;26(43):5435–40.PubMedCrossRef Garland S, Park SN, Ngan HY, Frazer I, Tay EH, Chen CJ, Bhatla N, Pitts M, Shin HR, Konno R, Smith J. The need for public education on HPV and cervical cancer prevention in Asia: opinions of experts at the AOGIN conference. Vaccine. 2008;26(43):5435–40.PubMedCrossRef
17.
Zurück zum Zitat Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.PubMedPubMedCentralCrossRef Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Abotchie PN, Shokar NK. Cervical cancer screening among college students in Ghana: knowledge and health beliefs. Int J Gynecol Cancer. 2009;19(3):412–6.PubMedPubMedCentralCrossRef Abotchie PN, Shokar NK. Cervical cancer screening among college students in Ghana: knowledge and health beliefs. Int J Gynecol Cancer. 2009;19(3):412–6.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Agboeze J, Nwali M, Ezeani N. Cervical cancer screening knowledge and behavior among female undergraduate students in a Nigerian University. J Glob Oncol. 2018;4(Supplement 2):3s.CrossRef Agboeze J, Nwali M, Ezeani N. Cervical cancer screening knowledge and behavior among female undergraduate students in a Nigerian University. J Glob Oncol. 2018;4(Supplement 2):3s.CrossRef
22.
Zurück zum Zitat Akujobi CN, Ikechebelu JI, Onunkwo I, Onyiaorah IV. Knowledge, attitude and practice of screening for cervical cancer among female students of a tertiary institution in South Eastern Nigeria. Niger J Clin Pract. 2008;11(3):216–9.PubMed Akujobi CN, Ikechebelu JI, Onunkwo I, Onyiaorah IV. Knowledge, attitude and practice of screening for cervical cancer among female students of a tertiary institution in South Eastern Nigeria. Niger J Clin Pract. 2008;11(3):216–9.PubMed
23.
Zurück zum Zitat Al-Naggar RA, Low WY, Isa ZM. Knowledge and barriers towards cervical cancer screening among young women in Malaysia. Asian Pac J Cancer Prev. 2010;11(4):867–73.PubMed Al-Naggar RA, Low WY, Isa ZM. Knowledge and barriers towards cervical cancer screening among young women in Malaysia. Asian Pac J Cancer Prev. 2010;11(4):867–73.PubMed
24.
Zurück zum Zitat Al-Shaikh GK, Almussaed EM, Fayed AA, Khan FH, Syed SB, Al-Tamimi TN, Elmorshedy HN. Knowledge of Saudi female university students regarding cervical cancer and acceptance of the human papilloma virus vaccine. Saudi Med J. 2014;35(10):1223.PubMedPubMedCentral Al-Shaikh GK, Almussaed EM, Fayed AA, Khan FH, Syed SB, Al-Tamimi TN, Elmorshedy HN. Knowledge of Saudi female university students regarding cervical cancer and acceptance of the human papilloma virus vaccine. Saudi Med J. 2014;35(10):1223.PubMedPubMedCentral
25.
Zurück zum Zitat Albuquerque CL, Costa MD, Nunes FM, Freitas RW, Azevedo PR, Fernandes JV, Rego JV, Barreto HM. Knowledge, attitudes and practices regarding the Pap test among women in northeastern Brazil. Sao Paulo Med J. 2014;132(1):3–9.PubMedCrossRef Albuquerque CL, Costa MD, Nunes FM, Freitas RW, Azevedo PR, Fernandes JV, Rego JV, Barreto HM. Knowledge, attitudes and practices regarding the Pap test among women in northeastern Brazil. Sao Paulo Med J. 2014;132(1):3–9.PubMedCrossRef
26.
Zurück zum Zitat Alwahaibi NY, Alramadhani NM, Alzaabi AM, Alsalami WA. Knowledge, attitude and practice of Pap smear among Omani women. Ann Trop Med Public Health. 2017;10(2):396.CrossRef Alwahaibi NY, Alramadhani NM, Alzaabi AM, Alsalami WA. Knowledge, attitude and practice of Pap smear among Omani women. Ann Trop Med Public Health. 2017;10(2):396.CrossRef
27.
Zurück zum Zitat Annan FM, Asante KO, Kugbey N. Perceived seriousness mediates the influence of cervical cancer knowledge on screening practices among female university students in Ghana. BMC Womens Health. 2019;19(1):1–8.CrossRef Annan FM, Asante KO, Kugbey N. Perceived seriousness mediates the influence of cervical cancer knowledge on screening practices among female university students in Ghana. BMC Womens Health. 2019;19(1):1–8.CrossRef
28.
Zurück zum Zitat Ayinde OA, Omigbodun AO, Ilesanmi AO. Awareness of cervical cancer, Papanicolaou’s smear and its utilisation among female undergraduates in Ibadan. Afr J Reprod Health. 2004;8:68–80.PubMedCrossRef Ayinde OA, Omigbodun AO, Ilesanmi AO. Awareness of cervical cancer, Papanicolaou’s smear and its utilisation among female undergraduates in Ibadan. Afr J Reprod Health. 2004;8:68–80.PubMedCrossRef
29.
Zurück zum Zitat Bigaard J, Mortensen JH, Kvernrød AB. Barriers for young women to participate in the Danish cervical screening program. J Global Oncol. 2018;4(Supplement 2):55s.CrossRef Bigaard J, Mortensen JH, Kvernrød AB. Barriers for young women to participate in the Danish cervical screening program. J Global Oncol. 2018;4(Supplement 2):55s.CrossRef
30.
Zurück zum Zitat Binka C, Nyarko SH, Doku DT. Cervical cancer knowledge, perceptions and screening behaviour among female university students in Ghana. J Cancer Educ. 2016;31(2):322–7.PubMedCrossRef Binka C, Nyarko SH, Doku DT. Cervical cancer knowledge, perceptions and screening behaviour among female university students in Ghana. J Cancer Educ. 2016;31(2):322–7.PubMedCrossRef
31.
Zurück zum Zitat Black AT, McCulloch A, Martin RE, Kan L. Young women and cervical cancer screening: what barriers persist? Can J Nurs Res Arch. 2011;8–21. Black AT, McCulloch A, Martin RE, Kan L. Young women and cervical cancer screening: what barriers persist? Can J Nurs Res Arch. 2011;8–21.
32.
Zurück zum Zitat Blomberg K, Tishelman C, Ternestedt BM, Törnberg S, Levál A, Widmark C. How can young women be encouraged to attend cervical cancer screening? Suggestions from face-to-face and internet focus group discussions with 30-year-old women in Stockholm, Sweden. Acta Oncol. 2011;50(1):112–20.PubMedCrossRef Blomberg K, Tishelman C, Ternestedt BM, Törnberg S, Levál A, Widmark C. How can young women be encouraged to attend cervical cancer screening? Suggestions from face-to-face and internet focus group discussions with 30-year-old women in Stockholm, Sweden. Acta Oncol. 2011;50(1):112–20.PubMedCrossRef
33.
Zurück zum Zitat Blomberg K, Widmark C, Ternestedt BM, Törnberg S, Tishelman C. Between youth and adulthood: focus group discussions with 30-year-old women about cervical cancer and its prevention in urban Sweden. Cancer Nurs. 2011;34(3):E11-20.PubMedCrossRef Blomberg K, Widmark C, Ternestedt BM, Törnberg S, Tishelman C. Between youth and adulthood: focus group discussions with 30-year-old women about cervical cancer and its prevention in urban Sweden. Cancer Nurs. 2011;34(3):E11-20.PubMedCrossRef
34.
Zurück zum Zitat Byrd TL, Peterson SK, Chavez R, Heckert A. Cervical cancer screening beliefs among young Hispanic women. Prev Med. 2004;38(2):192–7.PubMedCrossRef Byrd TL, Peterson SK, Chavez R, Heckert A. Cervical cancer screening beliefs among young Hispanic women. Prev Med. 2004;38(2):192–7.PubMedCrossRef
35.
Zurück zum Zitat Duffett-Leger LA, Letourneau NL, Croll JC. Cervical cancer screening practices among university women. J Obstet Gynecol Neonatal Nurs. 2008;37(5):572–81.PubMedCrossRef Duffett-Leger LA, Letourneau NL, Croll JC. Cervical cancer screening practices among university women. J Obstet Gynecol Neonatal Nurs. 2008;37(5):572–81.PubMedCrossRef
36.
Zurück zum Zitat Head KJ, Cohen EL. Young women’s perspectives on cervical cancer prevention in Appalachian Kentucky. Qual Health Res. 2012;22(4):476–87.PubMedCrossRef Head KJ, Cohen EL. Young women’s perspectives on cervical cancer prevention in Appalachian Kentucky. Qual Health Res. 2012;22(4):476–87.PubMedCrossRef
37.
Zurück zum Zitat Hobbs M. Adolescents had poor knowledge about Papanicolaou (cervical) smear screening and identified many barriers to being screened. Evid Based Nurs. 2000;3(3):188–95.CrossRef Hobbs M. Adolescents had poor knowledge about Papanicolaou (cervical) smear screening and identified many barriers to being screened. Evid Based Nurs. 2000;3(3):188–95.CrossRef
38.
Zurück zum Zitat Hoque ME. Awareness of cervical cancer, Papanicolau’s smear and its utilization among female, final year undergraduates in Durban, South Africa. J Cancer Res Ther. 2013;9(1):25.PubMedCrossRef Hoque ME. Awareness of cervical cancer, Papanicolau’s smear and its utilization among female, final year undergraduates in Durban, South Africa. J Cancer Res Ther. 2013;9(1):25.PubMedCrossRef
39.
Zurück zum Zitat Lorenzi NP, Termini L, Longatto Filho A, Tacla M, de Aguiar LM, Beldi MC, Ferreira-Filho ES, Baracat EC, Soares-Júnior JM. Age-related acceptability of vaginal self-sampling in cervical cancer screening at two university hospitals: a pilot cross-sectional study. BMC Public Health. 2019;19(1):963.PubMedPubMedCentralCrossRef Lorenzi NP, Termini L, Longatto Filho A, Tacla M, de Aguiar LM, Beldi MC, Ferreira-Filho ES, Baracat EC, Soares-Júnior JM. Age-related acceptability of vaginal self-sampling in cervical cancer screening at two university hospitals: a pilot cross-sectional study. BMC Public Health. 2019;19(1):963.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Jayasinghe Y, Rangiah C, Gorelik A, Ogilvie G, Wark JD, Hartley S, Garland SM. Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years. J Clin Virol. 2016;76:S74-80.PubMedCrossRef Jayasinghe Y, Rangiah C, Gorelik A, Ogilvie G, Wark JD, Hartley S, Garland SM. Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16–28 years. J Clin Virol. 2016;76:S74-80.PubMedCrossRef
41.
Zurück zum Zitat Jubelirer SJ, Blanton MF, Blanton PD, Zhang J, Foster D, Monk J, Kuhn G, Hanshew D. Assessment of knowledge, attitudes, and behaviors relative to cervical cancer and the Pap smear among adolescent girls in West Virginia. J Cancer Educ. 1996;11(4):230–2.PubMed Jubelirer SJ, Blanton MF, Blanton PD, Zhang J, Foster D, Monk J, Kuhn G, Hanshew D. Assessment of knowledge, attitudes, and behaviors relative to cervical cancer and the Pap smear among adolescent girls in West Virginia. J Cancer Educ. 1996;11(4):230–2.PubMed
42.
Zurück zum Zitat Kahn JA, Chiou V, Allen JD, Goodman E, Perlman SE, Emans SJ. Beliefs about Papanicolaou smears and compliance with Papanicolaou smear follow-up in adolescents. Arch Pediatr Adolesc Med. 1999;153(10):1046–54.PubMedCrossRef Kahn JA, Chiou V, Allen JD, Goodman E, Perlman SE, Emans SJ. Beliefs about Papanicolaou smears and compliance with Papanicolaou smear follow-up in adolescents. Arch Pediatr Adolesc Med. 1999;153(10):1046–54.PubMedCrossRef
43.
Zurück zum Zitat Kaneko N. Factors associated with cervical cancer screening among young unmarried Japanese women: results from an internet-based survey. BMC Womens Health. 2018;18(1):132.PubMedPubMedCentralCrossRef Kaneko N. Factors associated with cervical cancer screening among young unmarried Japanese women: results from an internet-based survey. BMC Womens Health. 2018;18(1):132.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Kim HW. Factors related to the perceptions of susceptibility and severity in cervix cancer among unmarried university women in Korea. J Women’s Health. 2014;23(4):29–29. Kim HW. Factors related to the perceptions of susceptibility and severity in cervix cancer among unmarried university women in Korea. J Women’s Health. 2014;23(4):29–29.
45.
Zurück zum Zitat Kim HW. Attitudetoward the PAP test among the sexually active unmarried women. J Women’s Health. 2019;28(6):2–3. Kim HW. Attitudetoward the PAP test among the sexually active unmarried women. J Women’s Health. 2019;28(6):2–3.
46.
47.
Zurück zum Zitat Lee HY, Lee MH. Barriers to cervical cancer screening and prevention in young Korean immigrant women: implications for intervention development. J Transcult Nurs. 2017;28(4):353–62.PubMedCrossRef Lee HY, Lee MH. Barriers to cervical cancer screening and prevention in young Korean immigrant women: implications for intervention development. J Transcult Nurs. 2017;28(4):353–62.PubMedCrossRef
48.
Zurück zum Zitat Najem GR, Batuman F, Smith AM. Papanicolaou test status among inner-city adolescent girls. Am J Prev Med. 1996;12(6):482–6.PubMedCrossRef Najem GR, Batuman F, Smith AM. Papanicolaou test status among inner-city adolescent girls. Am J Prev Med. 1996;12(6):482–6.PubMedCrossRef
49.
Zurück zum Zitat Ogbonna FS. Knowledge, attitude, and experience of cervical cancer and screening among Sub-saharan African female students in a UK University. Ann Afr Med. 2017;16(1):18.PubMedPubMedCentral Ogbonna FS. Knowledge, attitude, and experience of cervical cancer and screening among Sub-saharan African female students in a UK University. Ann Afr Med. 2017;16(1):18.PubMedPubMedCentral
50.
Zurück zum Zitat Okoeki MO, Steven A, Geddes L. Psychological factors affecting participation in cervical screening for young women: a qualitative study. Lancet. 2016;388:S82.CrossRef Okoeki MO, Steven A, Geddes L. Psychological factors affecting participation in cervical screening for young women: a qualitative study. Lancet. 2016;388:S82.CrossRef
51.
Zurück zum Zitat Oshima S, Maezawa M. Perception of cervical cancer screening among Japanese university students who have never had a pap smear: a qualitative study. Asian Pac J Cancer Prev. 2013;14(7):4313–8.PubMedCrossRef Oshima S, Maezawa M. Perception of cervical cancer screening among Japanese university students who have never had a pap smear: a qualitative study. Asian Pac J Cancer Prev. 2013;14(7):4313–8.PubMedCrossRef
52.
Zurück zum Zitat Pan XF, Zhao ZM, Sun J, Chen F, Wen QL, Liu K, Song GQ, Zhang JJ, Wen Y, Fu CJ, Yang CX. Acceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education. PLoS ONE. 2014;9(10):e110353.PubMedPubMedCentralCrossRef Pan XF, Zhao ZM, Sun J, Chen F, Wen QL, Liu K, Song GQ, Zhang JJ, Wen Y, Fu CJ, Yang CX. Acceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education. PLoS ONE. 2014;9(10):e110353.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Waller J, Jackowska M, Marlow L, Wardle J. Exploring age differences in reasons for nonattendance for cervical screening: a qualitative study. BJOG Int J Obstetr Gynaecol. 2012;119(1):26–32.CrossRef Waller J, Jackowska M, Marlow L, Wardle J. Exploring age differences in reasons for nonattendance for cervical screening: a qualitative study. BJOG Int J Obstetr Gynaecol. 2012;119(1):26–32.CrossRef
54.
Zurück zum Zitat Kahn JA, Goodman E, Slap GB, Huang B, Emans SJ. Intention to return for Papanicolaou smears in adolescent girls and young women. Pediatrics. 2001;108(2):333–41.PubMedCrossRef Kahn JA, Goodman E, Slap GB, Huang B, Emans SJ. Intention to return for Papanicolaou smears in adolescent girls and young women. Pediatrics. 2001;108(2):333–41.PubMedCrossRef
55.
Zurück zum Zitat Hoque ME, Ghuman S, Coopoosmay R, Van Hal G. Cervical cancer screening among university students in South Africa: use of health belief model. Int J Infect Dis. 2014;21:424.CrossRef Hoque ME, Ghuman S, Coopoosmay R, Van Hal G. Cervical cancer screening among university students in South Africa: use of health belief model. Int J Infect Dis. 2014;21:424.CrossRef
57.
Zurück zum Zitat Nabalamba, A., and W. Millar. 2007. “Going to the doctor”. Health Reports. Statistics Canada Catalogue no. 82–003. Vol. 18 no. 1. (accessed January 11, 2017) Nabalamba, A., and W. Millar. 2007. “Going to the doctor”. Health Reports. Statistics Canada Catalogue no. 82–003. Vol. 18 no. 1. (accessed January 11, 2017)
58.
Zurück zum Zitat Black WC, Nease Jr RF, Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Nat Cancer Inst. 1995;87(10):720–731. Black WC, Nease Jr RF, Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Nat Cancer Inst. 1995;87(10):720–731.
59.
Zurück zum Zitat Lam AC, Aggarwal R, Cheung S, Stewart EL, Darling G, Lam S, Xu W, Liu G, Kavanagh J. Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis. Lung Cancer. 2020. Lam AC, Aggarwal R, Cheung S, Stewart EL, Darling G, Lam S, Xu W, Liu G, Kavanagh J. Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis. Lung Cancer. 2020.
60.
Zurück zum Zitat Schootman M, Jeffe DB, Baker EA, Walker MS. Effect of area poverty rate on cancer screening across US communities. J Epidemiol Community Health. 2006;60(3):202–7.PubMedPubMedCentralCrossRef Schootman M, Jeffe DB, Baker EA, Walker MS. Effect of area poverty rate on cancer screening across US communities. J Epidemiol Community Health. 2006;60(3):202–7.PubMedPubMedCentralCrossRef
61.
Zurück zum Zitat Bennett KJ, Pumkam C, Bellinger JD, Probst JC. Cancer screening delivery in persistent poverty rural counties. J Primary Care Community Health. 2011;2(4):240–9.CrossRef Bennett KJ, Pumkam C, Bellinger JD, Probst JC. Cancer screening delivery in persistent poverty rural counties. J Primary Care Community Health. 2011;2(4):240–9.CrossRef
63.
Zurück zum Zitat Arnett MJ, Thorpe RJ, Gaskin DJ, Bowie JV, LaVeist TA. Race, medical mistrust, and segregation in primary care as usual source of care: findings from the exploring health disparities in integrated communities study. J Urban Health. 2016;93(3):456–67.PubMedPubMedCentralCrossRef Arnett MJ, Thorpe RJ, Gaskin DJ, Bowie JV, LaVeist TA. Race, medical mistrust, and segregation in primary care as usual source of care: findings from the exploring health disparities in integrated communities study. J Urban Health. 2016;93(3):456–67.PubMedPubMedCentralCrossRef
64.
Zurück zum Zitat McDonald JT, Kennedy S. Insights into the ‘healthy immigrant effect’: health status and health service use of immigrants to Canada. Soc Sci Med. 2004;59(8):1613–27.PubMedCrossRef McDonald JT, Kennedy S. Insights into the ‘healthy immigrant effect’: health status and health service use of immigrants to Canada. Soc Sci Med. 2004;59(8):1613–27.PubMedCrossRef
65.
Zurück zum Zitat Kennedy S, Kidd MP, McDonald JT, Biddle N. The healthy immigrant effect: patterns and evidence from four countries. J Int Migr Integr. 2015;16(2):317–32. Kennedy S, Kidd MP, McDonald JT, Biddle N. The healthy immigrant effect: patterns and evidence from four countries. J Int Migr Integr. 2015;16(2):317–32.
66.
Zurück zum Zitat Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, MacKinnon J, Giuliano A. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control. 2009;20(7):1129–38.PubMedCrossRef Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, MacKinnon J, Giuliano A. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control. 2009;20(7):1129–38.PubMedCrossRef
67.
Zurück zum Zitat Johnson CE, Mues KE, Mayne SL, Kiblawi AN. Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model. J Low Genit Tract Dis. 2008;12(3):232–41.PubMedCrossRef Johnson CE, Mues KE, Mayne SL, Kiblawi AN. Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model. J Low Genit Tract Dis. 2008;12(3):232–41.PubMedCrossRef
68.
Zurück zum Zitat Ferris DG, Batish S, Wright TC, Cushing C, Scott EH. A neglected lesbian health concern: cervical neoplasia. J Fam Pract. 1996;43(6):581–4.PubMed Ferris DG, Batish S, Wright TC, Cushing C, Scott EH. A neglected lesbian health concern: cervical neoplasia. J Fam Pract. 1996;43(6):581–4.PubMed
69.
Zurück zum Zitat Clark MA, Boehmer U, Rosenthal S. Cancer screening in lesbian and bisexual women and trans men. In: Cancer and the LGBT Community 2015 (pp. 83–98). Springer, Cham. Clark MA, Boehmer U, Rosenthal S. Cancer screening in lesbian and bisexual women and trans men. In: Cancer and the LGBT Community 2015 (pp. 83–98). Springer, Cham.
70.
Zurück zum Zitat Tracy JK, Lydecker AD, Ireland L. Barriers to cervical cancer screening among lesbians. J Womens Health. 2010;19(2):229–37.CrossRef Tracy JK, Lydecker AD, Ireland L. Barriers to cervical cancer screening among lesbians. J Womens Health. 2010;19(2):229–37.CrossRef
71.
Zurück zum Zitat Johnson M, Wakefield C, Garthe K. Qualitative socioecological factors of cervical cancer screening use among transgender men. Prev Med Rep. 2020;17:101052.PubMedPubMedCentralCrossRef Johnson M, Wakefield C, Garthe K. Qualitative socioecological factors of cervical cancer screening use among transgender men. Prev Med Rep. 2020;17:101052.PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Sundstrom B, Smith E, Delay C, Luque JS, Davila C, Feder B, Paddock V, Poudrier J, Pierce JY, Brandt HM. A reproductive justice approach to understanding women’s experiences with HPV and cervical cancer prevention. Soc Sci Med. 2019;232:289–97.PubMedCrossRef Sundstrom B, Smith E, Delay C, Luque JS, Davila C, Feder B, Paddock V, Poudrier J, Pierce JY, Brandt HM. A reproductive justice approach to understanding women’s experiences with HPV and cervical cancer prevention. Soc Sci Med. 2019;232:289–97.PubMedCrossRef
73.
Zurück zum Zitat Luszczynska A, Durawa AB, Scholz U, Knoll N. Empowerment beliefs and intention to uptake cervical cancer screening: three psychosocial mediating mechanisms. Women Health. 2012;52(2):162–81.PubMedCrossRef Luszczynska A, Durawa AB, Scholz U, Knoll N. Empowerment beliefs and intention to uptake cervical cancer screening: three psychosocial mediating mechanisms. Women Health. 2012;52(2):162–81.PubMedCrossRef
Metadaten
Titel
Barriers and facilitators for cervical cancer screening among adolescents and young people: a systematic review
verfasst von
Abirami Kirubarajan
Shannon Leung
Xinglin Li
Matthew Yau
Mara Sobel
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Women's Health / Ausgabe 1/2021
Elektronische ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-021-01264-x

Weitere Artikel der Ausgabe 1/2021

BMC Women's Health 1/2021 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.